BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31104773)

  • 1. A Recurrent Missense Variant in AP2M1 Impairs Clathrin-Mediated Endocytosis and Causes Developmental and Epileptic Encephalopathy.
    Helbig I; Lopez-Hernandez T; Shor O; Galer P; Ganesan S; Pendziwiat M; Rademacher A; Ellis CA; Hümpfer N; Schwarz N; Seiffert S; Peeden J; Shen J; Štěrbová K; Hammer TB; Møller RS; Shinde DN; Tang S; Smith L; Poduri A; Krause R; Benninger F; Helbig KL; Haucke V; Weber YG; ;
    Am J Hum Genet; 2019 Jun; 104(6):1060-1072. PubMed ID: 31104773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
    Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
    Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AP2M1 mediates autophagy-induced CLDN2 (claudin 2) degradation through endocytosis and interaction with LC3 and reduces intestinal epithelial tight junction permeability.
    Ganapathy AS; Saha K; Suchanec E; Singh V; Verma A; Yochum G; Koltun W; Nighot M; Ma T; Nighot P
    Autophagy; 2022 Sep; 18(9):2086-2103. PubMed ID: 34964704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.
    Olson HE; Jean-Marçais N; Yang E; Heron D; Tatton-Brown K; van der Zwaag PA; Bijlsma EK; Krock BL; Backer E; Kamsteeg EJ; Sinnema M; Reijnders MRF; Bearden D; Begtrup A; Telegrafi A; Lunsing RJ; Burglen L; Lesca G; Cho MT; Smith LA; Sheidley BR; Moufawad El Achkar C; Pearl PL; Poduri A; Skraban CM; Tarpinian J; Nesbitt AI; Fransen van de Putte DE; Ruivenkamp CAL; Rump P; Chatron N; Sabatier I; De Bellescize J; Guibaud L; Sweetser DA; Waxler JL; Wierenga KJ; ; Donadieu J; Narayanan V; Ramsey KM; ; Nava C; Rivière JB; Vitobello A; Tran Mau-Them F; Philippe C; Bruel AL; Duffourd Y; Thomas L; Lelieveld SH; Schuurs-Hoeijmakers J; Brunner HG; Keren B; Thevenon J; Faivre L; Thomas G; Thauvin-Robinet C
    Am J Hum Genet; 2018 May; 102(5):995-1007. PubMed ID: 29656858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies.
    Manivannan SN; Roovers J; Smal N; Myers CT; Turkdogan D; Roelens F; Kanca O; Chung HL; Scholz T; Hermann K; Bierhals T; Caglayan HS; Stamberger H; ; Mefford H; de Jonghe P; Yamamoto S; Weckhuysen S; Bellen HJ
    Brain; 2022 Jun; 145(5):1684-1697. PubMed ID: 34788397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semantic Similarity Analysis Reveals Robust Gene-Disease Relationships in Developmental and Epileptic Encephalopathies.
    Galer PD; Ganesan S; Lewis-Smith D; McKeown SE; Pendziwiat M; Helbig KL; Ellis CA; Rademacher A; Smith L; Poduri A; Seiffert S; von Spiczak S; Muhle H; van Baalen A; ; ; ; ; Thomas RH; Krause R; Weber Y; Helbig I
    Am J Hum Genet; 2020 Oct; 107(4):683-697. PubMed ID: 32853554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of clathrin-mediated endocytosis by hierarchical allosteric activation of AP2.
    Kadlecova Z; Spielman SJ; Loerke D; Mohanakrishnan A; Reed DK; Schmid SL
    J Cell Biol; 2017 Jan; 216(1):167-179. PubMed ID: 28003333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The
    Henrici RC; Edwards RL; Zoltner M; van Schalkwyk DA; Hart MN; Mohring F; Moon RW; Nofal SD; Patel A; Flueck C; Baker DA; Odom John AR; Field MC; Sutherland CJ
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental and epileptic encephalopathy in two siblings with a novel, homozygous missense variant in SCN1B.
    Darras N; Ha TK; Rego S; Martin PM; Barroso E; Slavotinek AM; Cilio MR
    Am J Med Genet A; 2019 Nov; 179(11):2190-2195. PubMed ID: 31465153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystonia as a prominent presenting feature in developmental and epileptic encephalopathies: A case series.
    Dzinovic I; Škorvánek M; Necpál J; Boesch S; Švantnerová J; Wagner M; Havránková P; Pavelekova P; Haň V; Janzarik WG; Berweck S; Diebold I; Kuster A; Jech R; Winkelmann J; Zech M
    Parkinsonism Relat Disord; 2021 Sep; 90():73-78. PubMed ID: 34399161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures.
    Myers CT; Stong N; Mountier EI; Helbig KL; Freytag S; Sullivan JE; Ben Zeev B; Nissenkorn A; Tzadok M; Heimer G; Shinde DN; Rezazadeh A; Regan BM; Oliver KL; Ernst ME; Lippa NC; Mulhern MS; Ren Z; Poduri A; Andrade DM; Bird LM; Bahlo M; Berkovic SF; Lowenstein DH; Scheffer IE; Sadleir LG; Goldstein DB; Mefford HC; Heinzen EL
    Am J Hum Genet; 2017 Oct; 101(4):516-524. PubMed ID: 28942967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dyslexia-associated protein KIAA0319 interacts with adaptor protein 2 and follows the classical clathrin-mediated endocytosis pathway.
    Levecque C; Velayos-Baeza A; Holloway ZG; Monaco AP
    Am J Physiol Cell Physiol; 2009 Jul; 297(1):C160-8. PubMed ID: 19419997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stonin 2 is an AP-2-dependent endocytic sorting adaptor for synaptotagmin internalization and recycling.
    Diril MK; Wienisch M; Jung N; Klingauf J; Haucke V
    Dev Cell; 2006 Feb; 10(2):233-44. PubMed ID: 16459302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clathrin adaptor AP-2 is essential for early embryonal development.
    Mitsunari T; Nakatsu F; Shioda N; Love PE; Grinberg A; Bonifacino JS; Ohno H
    Mol Cell Biol; 2005 Nov; 25(21):9318-23. PubMed ID: 16227583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission.
    Platzer K; Sticht H; Bupp C; Ganapathi M; Pereira EM; Le Guyader G; Bilan F; Henderson LB; Lemke JR; Taschenberger H; Brose N; Abou Jamra R; Wojcik SM
    Ann Neurol; 2022 Dec; 92(6):958-973. PubMed ID: 36073542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for association of PIPKI gamma-p90 with clathrin adaptor AP-2.
    Kahlfeldt N; Vahedi-Faridi A; Koo SJ; Schäfer JG; Krainer G; Keller S; Saenger W; Krauss M; Haucke V
    J Biol Chem; 2010 Jan; 285(4):2734-49. PubMed ID: 19903820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocytosis of cellulose synthase in Arabidopsis is dependent on μ2, a clathrin-mediated endocytosis adaptin.
    Bashline L; Li S; Anderson CT; Lei L; Gu Y
    Plant Physiol; 2013 Sep; 163(1):150-60. PubMed ID: 23843604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of the interaction between Dishevelled2 and clathrin AP-2 adaptor, a critical step in noncanonical Wnt signaling.
    Yu A; Xing Y; Harrison SC; Kirchhausen T
    Structure; 2010 Oct; 18(10):1311-20. PubMed ID: 20947020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Regulation of Clathrin and Its Adaptor Proteins during Membrane Recruitment for Endocytosis.
    Wang C; Hu T; Yan X; Meng T; Wang Y; Wang Q; Zhang X; Gu Y; Sánchez-Rodríguez C; Gadeyne A; Lin J; Persson S; Van Damme D; Li C; Bednarek SY; Pan J
    Plant Physiol; 2016 May; 171(1):215-29. PubMed ID: 26945051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional observation of a de novo pathogenic variant in KCNT2 leading to epileptic encephalopathy with clinical features of frontal lobe epilepsy.
    Inuzuka LM; Macedo-Souza LI; Della-Ripa B; Monteiro FP; Ramos L; Kitajima JP; Garzon E; Kok F
    Brain Dev; 2020 Oct; 42(9):691-695. PubMed ID: 32773162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.